{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:55:55Z","timestamp":1791363355823,"version":"4.3.1"},"reference-count":26,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Obstetrics and Gynaecology"],"published-print":{"date-parts":[[2003,1,1]]},"DOI":"10.1080\/01443610310000100060","type":"journal-article","created":{"date-parts":[[2004,6,28]],"date-time":"2004-06-28T19:30:53Z","timestamp":1088451053000},"page":"263-266","source":"Crossref","is-referenced-by-count":2,"title":["Are pharmacological considerations of relevance in hormone replacement therapy for prevention of chronic disease?"],"prefix":"10.1080","volume":"23","author":[{"given":"T. H.","family":"Lippert","sequence":"first","affiliation":[{"name":"Section of Clinical Pharmacology, Department of Obstetrics and Gynaecology University-Hospital Tuebingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Seeger","sequence":"additional","affiliation":[{"name":"Section of Clinical Pharmacology, Department of Obstetrics and Gynaecology University-Hospital Tuebingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Mueck","sequence":"additional","affiliation":[{"name":"Section of Clinical Pharmacology, Department of Obstetrics and Gynaecology University-Hospital Tuebingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","unstructured":"Adams M.R. Register T.C. Golden D.L. Wagner J.D. and Williams J.K. (1997) Medroxyprogesterone acetate anta-gonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 17 217\u2013221.","DOI":"10.1161\/01.ATV.17.1.217"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx990186j"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Cline J.M. Soderqvist G. von Schoultz E. Skoog L. and von Schoultz B. (1996) Effects of hormone replacement therapy on mammary gland of surgically postmenopausal cyno-molgus macaques. American Journal of Obstetrics and Gynecology 174 93\u2013100.","DOI":"10.1016\/S0002-9378(96)70379-4"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Cline J.M. Soderqvist G. von Schoultz E. Skoog L. and von Schoultz B. (1998) Effects of conjugated estrogens medroxy-progesterone and tamoxifen on the mammary glands of macaques. Breast Cancer Research and Treatment 48 221\u2013229.","DOI":"10.1023\/A:1005984932268"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.10.950"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/13621807990050S201"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.297.5580.325"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.366"},{"key":"e_1_2_1_10_1","unstructured":"Godsland I.F. (1998) Effects on carbohydrate metabolism. In: Estrogens and Progestogens in Clinical Practice edited by Fraser IS. Jansen R.P.S. Lobo R.A. and Whitehead MI. pp. 773\u2013785. London: Churchill Livingstone."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.1.49"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115129"},{"key":"e_1_2_1_13_1","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth L.J.","year":"1999","unstructured":"Hofseth L.J., Raafat A.M., Osuch J.R., Pathak DR., Slomski C.A. and Haslam S.Z. (1999) Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. Journal of Clinical Endocrinology and Metabolism, 84, 4559\u20134565.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_2_1_15_1","first-page":"223","article-title":"The composition of premarin","volume":"43","author":"Klein R","year":"1998","unstructured":"Klein R. (1998) The composition of premarin. International Journal of Fertility, 43, 223.","journal-title":"International Journal of Fertility"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)49215-0"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(00)00101-X"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00172.x"},{"issue":"4","key":"e_1_2_1_19_1","first-page":"26","article-title":"Pharmacology and toxicology of different estrogens","volume":"15","author":"Lippert T.H.","year":"2001","unstructured":"Lippert T.H., Seeger H. and Mueck A.O. (2001) Pharmacology and toxicology of different estrogens. Gynecological Endocrinology, 15 (Suppl. 4), 26\u201333.","journal-title":"Gynecological Endocrinology"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx0101649"},{"key":"e_1_2_1_21_1","unstructured":"Lobo R.A. Kelsey J. and Marcus R. (2000) Menopause Biology and Pathobiology. San Diego Academic Press."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137744.x"},{"key":"e_1_2_1_23_1","unstructured":"Parfitt K. (1999) Martindale The complete Drug Reference 32nd edition pp. 1457\u20131458. London Pharmaceutuical press."},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Ross R.K. Paganini-Hill A. Wan P.C. and Pike M.C. (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute 92 328\u2013332.","DOI":"10.1093\/jnci\/92.4.328"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Schairer C. Lubin J. Troisi R. Sturgeon S. Brinton L. and Hoover R. (2000) Menopausal estrogen and estrogen\u2014 progestin replacement therapy and breast cancer risk. Journal of the American Medical Association 283 485\u2013491.","DOI":"10.1001\/jama.283.4.485"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90184-8"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"}],"container-title":["Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01443610310000100060","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01443610310000100060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:48:19Z","timestamp":1791362899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01443610310000100060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,1,1]]}},"alternative-id":["10.1080\/01443610310000100060"],"URL":"https:\/\/doi.org\/10.1080\/01443610310000100060","relation":{},"ISSN":["0144-3615","1364-6893"],"issn-type":[{"value":"0144-3615","type":"print"},{"value":"1364-6893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}